{"transactions":[{"id":748139,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":40969,"kind":"person","name":"Boctor Fady","position":1,"cik":"0001833394","reported_name":"Boctor Fady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-05T21:25:09.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted shares (\"Shares\") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted shares (\"Shares\") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date."}],"balance_after":894986,"source":{"system":"sec-edgar","filing":"0001104659-26-071048","document":"tm2617013-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465926071048/tm2617013-3_4seq1.xml","form_type":"4"}},{"id":946962,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":40969,"kind":"person","name":"Boctor Fady","position":1,"cik":"0001833394","reported_name":"Boctor Fady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-06T22:30:07.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). 50% of the RSUs vested on the date of grant and the remaining 50% will vest on the six month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\"). 50% of the RSUs vested on the date of grant and the remaining 50% will vest on the six month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share (the \"Common Stock\"), of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amounts adjusted for the Issuer's 1-for-25 reverse stock split of the Issuer's Common Stock, effective as of 4:05 p.m. (New York time) on April 30, 2025."}],"balance_after":519986,"source":{"system":"sec-edgar","filing":"0001104659-26-001417","document":"tm261718-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465926001417/tm261718-2_4seq1.xml","form_type":"4"}},{"id":1253120,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":40969,"kind":"person","name":"Boctor Fady","position":1,"cik":"0001833394","reported_name":"Boctor Fady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-21T22:31:45.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date."}],"balance_after":499645,"source":{"system":"sec-edgar","filing":"0001104659-25-016200","document":"tm257316-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465925016200/tm257316-2_4seq1.xml","form_type":"4"}},{"id":1700181,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":40969,"kind":"person","name":"Boctor Fady","position":1,"cik":"0001833394","reported_name":"Boctor Fady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-26T22:07:49.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":54533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vested 50% upon the date of grant, and the remainder vests upon the achievement of certain performance goals, provided that the Reporting Person has continued to provide services to the Company through the vesting date."}],"balance_after":54533,"derivative":{"exercise_price":1.41,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":54533},"source":{"system":"sec-edgar","filing":"0001104659-23-129254","document":"tm2333705-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923129254/tm2333705-6_4seq1.xml","form_type":"4"}},{"id":1700180,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":40969,"kind":"person","name":"Boctor Fady","position":1,"cik":"0001833394","reported_name":"Boctor Fady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-26T22:07:49.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":49645,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49645,"source":{"system":"sec-edgar","filing":"0001104659-23-129254","document":"tm2333705-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923129254/tm2333705-6_4seq1.xml","form_type":"4"}},{"id":2826903,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":40969,"kind":"person","name":"Boctor Fady","position":1,"cik":"0001833394","reported_name":"Boctor Fady","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. & Chief Comm. Officer"}}],"security":"Stock Options (right to buy)","published_at":"2021-03-02T00:16:09.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":215669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vested 50% as of February 19, 2021, the date of grant, and the remainder vest in equal installments on the first and second annual anniversaries thereof."}],"balance_after":215669,"derivative":{"exercise_price":3.74,"expiration_date":"2031-02-19","underlying":"Common Stock","underlying_shares":215669},"source":{"system":"sec-edgar","filing":"0001567619-21-005214","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761921005214/doc1.xml","form_type":"4"}}]}